A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Systematic Review of Coronavirus Disease 2019 Vaccine Efficacy and Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Disease
Authors
Keywords
-
Journal
Open Forum Infectious Diseases
Volume 9, Issue 6, Pages -
Publisher
Oxford University Press (OUP)
Online
2022-04-19
DOI
10.1093/ofid/ofac138
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
- (2022) Manuela Di Fusco et al. Expert Review of Vaccines
- Short-term effectiveness of COVID-19 vaccines in immunocompromised patients: A systematic literature review and meta-analysis
- (2022) Alexandre R. Marra et al. JOURNAL OF INFECTION
- The effectiveness of mRNA‐1273 vaccine against COVID‐19 caused by Delta variant: A systematic review and meta‐analysis
- (2022) Chia S. Kow et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial
- (2022) Lulu Bravo et al. LANCET
- Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
- (2022) Elisabetta Cameroni et al. NATURE
- Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
- (2022) Laith J. Abu-Raddad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines
- (2022) Nick Andrews et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants
- (2022) David W. Eyre et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel
- (2022) Ottavia Prunas et al. SCIENCE
- COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales
- (2022) Stuart Bedston et al. VACCINE
- Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant
- (2022) Baisheng Li et al. Nature Communications
- Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
- (2022) Daniel R Feikin et al. LANCET
- Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection
- (2021) Jennifer M. Dan et al. SCIENCE
- Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity
- (2021) Wilfredo F. Garcia-Beltran et al. CELL
- Impact of the COVID-19 Vaccine on Asymptomatic Infection Among Patients Undergoing Pre-Procedural COVID-19 Molecular Screening
- (2021) Aaron J Tande et al. CLINICAL INFECTIOUS DISEASES
- Are some COVID vaccines better than others? Interpreting and comparing estimates of efficacy in trials of COVID-19 vaccines
- (2021) Rekha R Rapaka et al. CLINICAL INFECTIOUS DISEASES
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
- (2021) Noa Dagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers
- (2021) Yoel Angel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study
- (2021) Eleftheria Vasileiou et al. LANCET
- Population immunity and vaccine protection against infection
- (2021) Eyal Leshem et al. LANCET
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
- (2021) Eric J Haas et al. LANCET
- Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial
- (2021) Katherine R W Emary et al. LANCET
- Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine
- (2021) Matan Levine-Tiefenbrun et al. NATURE MEDICINE
- Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Shabir A. Madhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
- (2021) Vivek Shinde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparative systematic review and meta-analysis of reactogenicity, immunogenicity and efficacy of vaccines against SARS-CoV-2
- (2021) Ian McDonald et al. npj Vaccines
- A global database of COVID-19 vaccinations
- (2021) Edouard Mathieu et al. Nature Human Behaviour
- An Updated Review of SARS-CoV-2 Vaccines and the Importance of Effective Vaccination Programs in Pandemic Times
- (2021) Cielo García-Montero et al. Vaccines
- SARS-CoV-2 Vaccine Effectiveness in a High-Risk National Population in a Real-World Setting
- (2021) Adeel A. Butt et al. ANNALS OF INTERNAL MEDICINE
- Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada
- (2021) Sara Carazo et al. CLINICAL INFECTIOUS DISEASES
- Risk of Reinfection After Seroconversion to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Population-based Propensity-score Matched Cohort Study
- (2021) Antonio Leidi et al. CLINICAL INFECTIOUS DISEASES
- To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination
- (2021) Nan-Chang Chiu et al. Expert Review of Vaccines
- Accelerated COVID-19 vaccine development: milestones, lessons, and prospects
- (2021) Karin Bok et al. IMMUNITY
- Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults
- (2021) Nawal Al Kaabi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
- (2021) Xinxue Liu et al. LANCET
- SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- (2021) Aziz Sheikh et al. LANCET
- Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey
- (2021) Mine Durusu Tanriover et al. LANCET
- Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control study
- (2021) Catherine Hyams et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1/2 trial
- (2021) ShengLi Xia et al. LANCET INFECTIOUS DISEASES
- Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study
- (2021) Madhumita Shrotri et al. LANCET INFECTIOUS DISEASES
- Mix-and-match COVID vaccines: the case is growing, but questions remain
- (2021) Dyani Lewis NATURE
- mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar
- (2021) Hiam Chemaitelly et al. NATURE MEDICINE
- Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination
- (2021) Tina Schmidt et al. NATURE MEDICINE
- Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination
- (2021) Joana Barros-Martins et al. NATURE MEDICINE
- Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom
- (2021) Emma Pritchard et al. NATURE MEDICINE
- Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy
- (2021) Noa Dagan et al. NATURE MEDICINE
- Effect of Vaccination on Transmission of SARS-CoV-2
- (2021) Anoop S.V. Shah et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
- (2021) Jamie Lopez Bernal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
- (2021) Alejandro Jara et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
- (2021) Robert W. Frenck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine
- (2021) Paul T. Heath et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
- (2021) Johan Normark et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of mRNA Covid-19 Vaccine among U.S. Health Care Personnel
- (2021) Tamara Pilishvili et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
- (2021) Ross J. Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
- (2021) Stephen J. Thomas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization
- (2021) Minal K. Patel et al. VACCINE
- Interpreting vaccine efficacy trial results for infection and transmission
- (2021) Marc Lipsitch et al. VACCINE
- BNT162b2 vaccine uptake and effectiveness in UK healthcare workers – a single centre cohort study
- (2021) Tariq Azamgarhi et al. Nature Communications
- Why Taiwan approved its own vaccine before phase III trials
- (2021) Andrew Silver BMJ-British Medical Journal
- Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study
- (2021) Otavio T Ranzani et al. BMJ-British Medical Journal
- Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
- (2021) David Hillus et al. Lancet Respiratory Medicine
- Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
- (2021) Srinivas Nanduri et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021
- (2021) Shaun J. Grannis et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021
- (2021) Wesley H. Self et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
- (2021) Jia Wei et al. Nature Microbiology
- Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis
- (2021) Haoyue Cheng et al. Vaccines
- Interim Estimates of COVID-19 Vaccine Effectiveness in a Mass Vaccination Setting: Data from an Italian Province
- (2021) Maria Elena Flacco et al. Vaccines
- Assessing COVID-19 Vaccine Uptake and Effectiveness Through the North West London Vaccination Program: Retrospective Cohort Study
- (2021) Ben Glampson et al. JMIR Public Health and Surveillance
- Effects of BNT162b2 mRNA vaccine on COVID-19 infection and hospitalisation amongst older people: matched case control study for England
- (2021) Thomas F. D. Mason et al. BMC Medicine
- Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals
- (2021) Chun Huai Luo et al. CLINICAL INFECTIOUS DISEASES
- BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients
- (2021) Sivan Gazit et al. CLINICAL INFECTIOUS DISEASES
- Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study
- (2021) Khitam Muhsen et al. CLINICAL INFECTIOUS DISEASES
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
- (2021) Thibault Fiolet et al. CLINICAL MICROBIOLOGY AND INFECTION
- Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study
- (2021) Zoltán Vokó et al. CLINICAL MICROBIOLOGY AND INFECTION
- A Systematic Review of the Protective Effect of Prior SARS-CoV-2 Infection on Repeat Infection
- (2021) N. Kojima et al. EVALUATION & THE HEALTH PROFESSIONS
- SARS-CoV-2 (Covid-19) vaccines structure, mechanisms and effectiveness: A review
- (2021) Hadis Fathizadeh et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
- (2021) Laith J. Abu-Raddad et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial
- (2021) Scott A Halperin et al. LANCET
- Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- (2021) Raches Ella et al. LANCET
- Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
- (2021) Alasdair P S Munro et al. LANCET
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
- (2021) Koen B. Pouwels et al. NATURE MEDICINE
- Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa
- (2021) Shirley Collie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning Immunity after the BNT162b2 Vaccine in Israel
- (2021) Yair Goldberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine
- (2021) Ann R. Falsey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
- (2021) Stephen M. Kissler et al. NEW ENGLAND JOURNAL OF MEDICINE
- BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant
- (2021) Aziz Sheikh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
- (2021) Emmanuel B. Walter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
- (2021) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill—An interim analysis of a nationwide cohort study
- (2021) Ulrike Baum et al. PLoS One
- Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in Israel
- (2021) Yaki Saciuk et al. PREVENTIVE MEDICINE
- Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021
- (2021) Eero Poukka et al. VACCINE
- Early effectiveness of BNT162b2 Covid-19 vaccine in preventing SARS-CoV-2 infection in healthcare personnel in six Israeli hospitals (CoVEHPI)
- (2021) Mark A. Katz et al. VACCINE
- Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
- (2021) Matt D. T. Hitchings et al. Nature Communications
- Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England
- (2021) Gayatri Amirthalingam et al. Nature Communications
- Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study
- (2021) Katia J Bruxvoort et al. BMJ-British Medical Journal
- Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study
- (2021) Mie Agermose Gram et al. PLOS MEDICINE
- High level of protection against COVID-19 after two doses of BNT162b2 vaccine in the working age population – first results from a cohort study in Southern Sweden
- (2021) Jonas Björk et al. Infectious Diseases
- Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans — Five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021
- (2021) Kristina L. Bajema et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data
- (2021) Aharona Glatman-Freedman et al. EBioMedicine
- The Effectiveness of Post-Vaccination and Post-Infection Protection in the Hospital Staff of Three Prague Hospitals: A Cohort Study of 8-Month Follow-Up from the Start of the COVID-19 Vaccination Campaign (COVANESS)
- (2021) Marek Petráš et al. Vaccines
- Effectiveness of the WHO-Authorized COVID-19 Vaccines: A Rapid Review of Global Reports till 30 June 2021
- (2021) Chang-Jie Cheng et al. Vaccines
- Analysis of the Effectiveness of the Ad26.COV2.S Adenoviral Vector Vaccine for Preventing COVID-19
- (2021) Juan Corchado-Garcia et al. JAMA Network Open
- Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study
- (2021) Devashish Desai et al. LANCET INFECTIOUS DISEASES
- Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial
- (2021) Peter G Kremsner et al. LANCET INFECTIOUS DISEASES
- An interactive web-based dashboard to track COVID-19 in real time
- (2020) Ensheng Dong et al. LANCET INFECTIOUS DISEASES
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19
- (2020) F. Javier Ibarrondo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Characteristics of Adult Outpatients and Inpatients with COVID-19 — 11 Academic Medical Centers, United States, March–May 2020
- (2020) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Will SARS-CoV-2 Infection Elicit Long-Lasting Protective or Sterilising Immunity? Implications for Vaccine Strategies (2020)
- (2020) David S. Kim et al. Frontiers in Immunology
- What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2
- (2020) Susanne H Hodgson et al. LANCET INFECTIOUS DISEASES
- A framework for research on vaccine effectiveness
- (2018) Natasha S. Crowcroft et al. VACCINE
- GISAID: Global initiative on sharing all influenza data – from vision to reality
- (2017) Yuelong Shu et al. Eurosurveillance
- Differences in Human Immunodeficiency Virus Care and Treatment Among Subpopulations in the United States
- (2013) H. Irene Hall et al. JAMA Internal Medicine
- Vaccine Epidemiology: Efficacy, Effectiveness, and the Translational Research Roadmap
- (2010) Geoffrey A. Weinberg et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More